Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-06-09 | Redeye | Redeye: I-Tech - Review on Regulatory News | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-02 | I-tech | I-Tech sales in Korea increase by 147% for the first half of 2023 compared to the same period in 2022. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-02 | I-tech | I-Tech ökar sin försäljning i Korea med 147% första halvåret 2023 jämfört med samma period 2022. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | I-tech | Bolagsuppdatering med anledning av omregistrering av Selektope i EU (webcast) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | I-tech | Company update regarding the renewal process for Selektope in the EU (webcast) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | I-tech | Expert panel suggests changed classification of Selektope | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | I-tech | Expertpanel föreslår ändrad klassificering för Selektope | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | I-tech | KOMMUNIKÉ FRÅN ÅRSTÄMMA 2023 I-TECH AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-08 | Redeye | Redeye: I-Tech - Q1 Review – Marching On | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | I-tech | I-Tech AB (publ) Interim report Q1 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-04 | I-tech | I-Tech AB (publ) Delårsrapport Q1 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-11 | I-Tech | I-Tech: KALLELSE TILL ÅRSSTÄMMA I I-TECH AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-06 | I-Tech | I-Tech's Annual Report 2022 is now published | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-06 | I-Tech | I-Techs årsredovisning för 2022 är nu publicerad | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-27 | Redeye | Redeye: I-Tech - Q4 Review – Raising the Bar | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-23 | I-Tech | RÄTTELSE: Större valutajusterad tillväxt än tidigare angivet - I-Tech AB (publ) Bokslutskommuniké Q4 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-23 | I-Tech | CORRECTION: Higher currency adjusted growth than earlier noted - I-Tech AB (publ) Year-end report 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-22 | I-Tech | I-Tech AB (publ) Bokslutskommuniké 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-02-22 | I-Tech | I-Tech AB (publ) Year-end report 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-11-18 | I-Tech | I-Techs valberedning utsedd | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2022-11-17 | Redeye | Redeye: I-Tech - Q3 Review – Increased profitability | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-21 | I-Tech | I-Tech AB (publ) Interim report Q3 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-10-21 | I-Tech | I-Tech AB (publ) Delårsrapport Q3 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-08-31 | Redeye | Redeye: I-Tech - Solid Momentum Ahead of H2’22 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | I-Tech | Correction - missing MAR label in earlier press release - I-Tech AB (publ) Interim report Q2 2022 | Rapporter | Ladda ner | Visa Stäng |
Rapporter |
Correction – missing MAR label in earlier press release – I-Tech AB (publ) Interim report Q2 2022I-Tech AB (publ) issues a correction to the press release that was published earlier today. The correction refers to the fact that the press release lacked a MAR label with reference to the EU’s Market Abuse Regulation (MAR). The following text should have been included in the press release: This disclosure contains information that I-Tech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 26-08-2022 08:00 CET. Summary of the period ” Record strong sales with increased profitability ”
April to June 2022
Important events after the period
Financial Summary All amounts in TSEK 2022Apr 2021Apr 2022Jan-Jun 2021Jan-Jun 2021Jan-Dec CEO Comments The second quarter marked record strong numbers with increased turnover, improved profitability and strong positive cash flow compared to previous year. Overall, I am satisfied that we are back on a growth curve and at the same time continuing to improve profitability. This demonstrates the strength of the business model already at low market shares. Also, the performance of the second quarter gives further confidence that our product, Selektope adds value to a wider customer base. The turnover of the period amounted to SEK 17.7 (12.8) million, representing a top line growth of 38% (-21%) and the operating profit after tax amounted to SEK 1.5 (-2.4) million. Cash flow amounted to SEK 3.2 (-7.6) million. From these perspectives, the results of the quarter are the best the company has shown so far and the 12-month rolling EBITDA results show a shift in trends towards growth. The results are supported by an increase in turnover on all accounts, where the largest change compared to last year relates to our smaller accounts. They show an increase in turnover of 89%, which means that the accounts excluding Chugoku Marine Paints (CMP) increased from approx. 20% to approx. 30% of the total turnover. The increased demand in combination with the customer mix largely explains the increase in turnover. However, it is to be noted that the favourable valuation of the US dollar has a clear contribution to the figures. The currency adjusted turnover increase amounted to 15% relative to the same period last year. The revenue for the quarter comes both from newbuilding activities in Southeast Asia but also a continuous stream of activity within the dry docking segment in which Korea and Japan have played important roles. Considering the comparable quarters, we take note of an increase in revenue towards the newbuilding market. During the quarter, the company was also enriched with a new board member, Dr Raouf Kattan, who has spent most of his professional life within the coating industry. Raouf has founded one of the industry’s most recognised coating engineering companies, the Safinah Group and holds strong academic merits. Earlier during the quarter, the company decided to move to nearby premises within the framework of GoCo Health Innovation City in Mölndal, where we can continue to increase our lab-intensive development work. The move takes place during the first quarter of 2023. Looking at the development from the first half of the year, a turnover of SEK 32.1 (27.3) million is noted, corresponding to a net turnover of 18% (-8%). The profit after tax amounted to SEK 2.0 (-2.0) million and the EBITDA trend continued to show black figures since middle of 2019 and grew to SEK 5.6 (0.8) million for the quarter. Knowing that there are many external factors that can and will influence our business in the future and hence create volatility, the quarter indicates a strong growing contribution from a broader customer base. Furthermore, there are signs of a shift in trends in the mindset around antifouling coatings which benefits reliable high-performance coatings contributing to increased fuel efficiency and reduced emissions. I am further convinced that our product is part of this important transition to a more efficient shipping industry. Philip Chaabane, CEO M: +46 73 910 37 08 About I-Tech AB I-Tech is a biotechnology company that has developed the product Selektope®, an active agent that prevents barnacle attachment on submerged surfaces such as ships and boat hulls, but also other marine installations. By increasing the resistance to barnacle growth in marine paint systems (e.g. antifouling coatings), fuel and maintenance costs are reduced. I-Tech has obtained the necessary regulatory approvals for Selektope® and has several of the world’s largest manufacturers of marine antifouling coatings as customers. The company’s share is listed for trading on Nasdaq First North Growth Market in Stockholm with Erik Penser Bank as Certified Adviser, phone: +46 (0)8 463 83 00, About Selektope® Selektope® introduces, for the first time, a pharmacological mode of action to combat barnacle settlement. By temporarily stimulating the octopamine receptor, the barnacle larvae’s swimming behavior is activated and the organisms are deterred from the hull. These ground-breaking discoveries enable unrivalled power at very low concentrations, yet within the limits of rigorous risk assessments. Selektope® is an organic, non-metal compound with efficacy proven at 0.1% w/w. For more information visit our website www.selektope.com This disclosure contains information that I-Tech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 26-08-2022 08:00 CET. |
||||
2022-08-26 | I-Tech | RÄTTELSE: Saknad MAR-etikett i tidigare pressmeddelande - I-Tech AB (publ) Delårsrapport Q2 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | I-Tech | I-Tech AB (publ) Interim report Q2 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2022-08-26 | I-Tech | I-Tech AB (publ) Delårsrapport Q2 2022 | Rapporter | Ladda ner | Visa Stäng |
|